Debridement, antibiotics, and implant retention in non-oncological femoral megaprosthesis infections: minimum 5 year follow-up
Tóm tắt
Megaprostheses are increasingly utilised outside of the oncological setting, and remain at significant risk of periprosthetic joint infection (PJI). Debridement, antibiotic, and implant retention (DAIR) is an established treatment for PJI, however its use in non-oncological patients with femoral megaprostheses has not been widely reported. There are significant differences in patient physiology, treatment goals, and associated risks between these patient cohorts. We identified 14 patients who underwent DAIR for a PJI of their femoral megaprostheses, between 2000 and 2014, whom had their index procedure secondary to non-oncological indications. Patients were managed as part of a multidisciplinary team, with our standardised surgical technique including exchange of all mobile parts, and subsequent antibiotic therapy for a minimum of 3 months. Patients were followed up for a minimum of 5 years. Patients included six proximal femoral replacements, five distal femoral replacements, and three total femoral replacements. No patients were lost to follow-up. There were six males and eight females, with a mean age of 67.2 years, and mean ASA of 2.3. Nine patients (64.3%) successfully cleared their infection following DAIR at a minimum of 5 year follow-up. Five patients (35.7%) required further revision surgery, with four patients cleared of infection. No patients who underwent DAIR alone suffered complications as a result of the procedure. The use of DAIR in these complex patients can lead to successful outcomes, but the risk of further revision remains high. The success rate (64.3%) remains on par with other studies evaluating DAIR in megaprostheses and in primary arthroplasty. This study indicates judicious use of DAIR can be an appropriate part of the treatment algorithm. II
Tài liệu tham khảo
Ercolano LB, Christensen T, McGough R, Weiss K (2013) Treatment solutions are unclear for Perimegaprosthetic infections. Clin Orthop Relat Res 471:3204–3213
Nucci N, Gazendam A, Gouveia K, Ghert M, Wilson D (2020) Management of infected extremity endoprostheses: a systematic review. Eur J Orthop Surg Traumatol 30:1139–1149
Calori GM, Colombo M, Malagoli E, Mazzola S, Bucci M, Mazza E (2014) Megaprosthesis in post-traumatic and periprosthetic large bone defects: issues to consider. Injury 45:S105–S110
Evans S, Laugharne E, Kotecha A, Hadley L, Ramasamy A, Jeys L (2016) Megaprostheses in the management of trauma of the knee. J Orthop 13:467–471
Höll S, Schlomberg A, Gosheger G, Dieckmann R, Streitbuerger A, Schulz D, Hardes J (2012) Distal femur and proximal tibia replacement with megaprosthesis in revision knee arthroplasty: a limb-saving procedure. Knee Surg Sports Traumatol Arthrosc 20:2513–2518
Haddad FS, Oussedik S, Meek RMD, Konan S, Stockley I, Gant V (2018) Orthopaedic infection: is consensus the answer. Bone Jt J 100-B:1405–1406
Hartzler MA, Li K, Geary MB, Odum SM, Springer BD (2020) Complications in the treatment of prosthetic joint infection: when do they occur? Bone Jt J 102-B:145–150
Svensson K, Rolfson O, Mohaddes M, Malchau H, Erichsen Andersson A (2020) Reflecting on and managing the emotional impact of prosthetic joint infections on orthopaedic surgeons—a qualitative study. Bone Jt J 102-B:736–743
Grammatopoulos G, Alvand A, Martin H, Whitwell D, Taylor A, Gibbons CLMH (2016) Five-year outcome of proximal femoral endoprosthetic arthroplasty for non-tumour indications. Bone Jt J 98-B:1463–1470
Jeys LM, Grimer RJ, Carter SR, Tillman RM (2005) Periprosthetic Infection in Patients Treated for an Orthopaedic Oncological Condition: J Bone Jt Surg 87:842–849
Jeys LM, Kulkarni A, Grimer RJ, Carter SR, Tillman RM, Abudu A (2008) Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am 90:1265–1271
Li X, Moretti VM, Ashana AO, Lackman RD (2011) Perioperative infection rate in patients with osteosarcomas treated with resection and prosthetic reconstruction. Clin Orthop Relat Res 469:2889–2894
Medellin MR, Fujiwara T, Clark R, Stevenson JD, Parry M, Jeys L (2019) Mechanisms of failure and survival of total femoral endoprosthetic replacements. Bone Jt J 101-B:522–528
Myers GJC, Abudu AT, Carter SR, Tillman RM, Grimer RJ (2007) Endoprosthetic replacement of the distal femur for bone tumours: long-term results. J Bone Joint Surg Br 89:521–526
Capanna R, Morris HG, Campanacci D, Del Ben M, Campanacci M (1994) Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur. J Bone Joint Surg Br 76:178–186
Grammatopoulos G, Bolduc M-E, Atkins BL, Kendrick BJL, McLardy-Smith P, Murray DW, Gundle R, Taylor AH (2017) Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: a case–control study. Bone Jt J 99-B:614–622
Ibrahim MS, Raja S, Khan MA, Haddad FS (2014) A multidisciplinary team approach to two-stage revision for the infected hip replacement: a minimum five-year follow-up study. Bone Jt J 96-B:1312–1318
Khan N, Parmar D, Ibrahim MS, Kayani B, Haddad FS (2019) Outcomes of repeat two-stage exchange hip arthroplasty for prosthetic joint infection. Bone Jt J 101-B:110–115
van den Kieboom J, Tirumala V, Box H, Oganesyan R, Klemt C, Kwon Y-M (2021) One-stage revision is as effective as two-stage revision for chronic culture-negative periprosthetic joint infection after total hip and knee arthroplasty: a retrospective cohort study. Bone Jt J 103-B:515–521
Tsang S-TJ, Ting J, Simpson AHRW, Gaston P (2017) Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: a review of cohort studies. Bone Jt J 99-B:1458–1466
Allison MD, Huang E, Ahlmann E, Carney S, Wang L, Menendez L (2014) Peri-prosthetic infection in the orthopedic tumor patient. Reconstr Rev 4:13–17
Dhanoa A, Ajit Singh V, Elbahri H (2015) Deep infections after Endoprosthetic replacement operations in orthopedic oncology patients. Surg Infect 16:323–332
Donati D, D’Arenzo R, Ercolani C, Boriani S (1995) Infection in limb salvage surgery for bone tumors. Eur J Orthop Surg Traumatol 5:71–74
Peel T, May D, Buising K, Thursky K, Slavin M, Choong P (2014) Infective complications following tumour endoprosthesis surgery for bone and soft tissue tumours. Eur J Surg Oncol EJSO 40:1087–1094
Funovics PT, Hipfl C, Hofstaetter JG, Puchner S, Kotz RI, Dominkus M (2011) Management of septic complications following modular endoprosthetic reconstruction of the proximal femur. Int Orthop 35:1437–1444
Toepfer A, Harrasser N, Schwarz P-R, Pohlig F, Lenze U, Mühlhofer HML, Gerdesmeyer L, von Eisenhart-Rothe R, Suren C (2017) Distal femoral replacement with the MML system: a single center experience with an average follow-up of 86 months. BMC Musculoskelet Disord 18:206
McNally M, Sousa R, Wouthuyzen-Bakker M, Chen AF, Soriano A, Vogely HC, Clauss M, Higuera CA, Trebše R (2021) The EBJIS definition of periprosthetic joint infection: a practical guide for clinicians. Bone Jt J 103-B:18–25
Karczewski D, Winkler T, Renz N, Trampuz A, Lieb E, Perka C, Müller M (2019) A standardized interdisciplinary algorithm for the treatment of prosthetic joint infections: outcome in a centralized and specialized department. Bone Jt J 101-B:132–139
Sendi P, Lötscher PO, Kessler B, Graber P, Zimmerli W, Clauss M (2017) Debridement and implant retention in the management of hip periprosthetic joint infection: outcomes following guided and rapid treatment at a single Centre. Bone Jt J 99-B:330–336
Zhang C, He L, Fang X, Huang Z, Bai G, Li W, Zhang W (2020) Debridement, antibiotics, and implant retention for acute Periprosthetic joint infection. Orthop Surg 12:463–470
Shohat N, Goswami K, Tan TL, Yayac M, Soriano A, Sousa R, Wouthuyzen-Bakker M, Parvizi J, On behalf of the ESCMID Study Group of Implant Associated Infections (ESGIAI) and the Northern Infection Network of Joint Arthroplasty (NINJA) (2020) 2020 frank Stinchfield award: identifying who will fail following irrigation and debridement for prosthetic joint infection: a machine learning-based validated tool. Bone Jt J 102-B:11–19
Goh GS, Parvizi J (2021) Think twice before prescribing antibiotics for that swollen knee: the influence of antibiotics on the diagnosis of Periprosthetic joint infection. Antibiot Basel Switz 10:114
Yang J, Parvizi J, Hansen EN, Culvern CN, Segreti JC, Tan T, Hartman CW, Sporer SM, Della Valle CJ, The Knee Society Research Group (2020) 2020 mark Coventry award: microorganism-directed oral antibiotics reduce the rate of failure due to further infection after two-stage revision hip or knee arthroplasty for chronic infection: a multicentre randomized controlled trial at a minimum of two years. Bone Jt J 102-B:3–9
Parvizi J, Erkocak OF, Della Valle CJ (2014) Culture-negative periprosthetic joint infection. J Bone Joint Surg Am 96:430–436
Malekzadeh D, Osmon DR, Lahr BD, Hanssen AD, Berbari EF (2010) Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection. Clin Orthop 468:2039–2045
Bedenčič K, Kavčič M, Faganeli N, Mihalič R, Mavčič B, Dolenc J, Bajc Z, Trebše R (2016) Does preoperative antimicrobial prophylaxis influence the diagnostic potential of Periprosthetic tissues in hip or knee infections? Clin Orthop 474:258–264
Wouthuyzen-Bakker M, Tornero E, Claret G, Bosch J, Martinez-Pastor JC, Combalia A, Soriano A (2017) Withholding preoperative antibiotic prophylaxis in knee prosthesis revision: a retrospective analysis on culture results and risk of infection. J Arthroplast 32:2829–2833
Ascione T, Barrack R, Benito N, Blevins K, Brause B, Cornu O, Frommelt L, Gant V, Goswami K, Hu R, Klement MR, Komnos G, Malhotra R, Mirza Y, Munhoz Lima AL, Nelson C, Noor SS, O’Malley M, Oussedik S, Portillo ME, Prieto H, Saxena A, Sessa G (2019) General assembly, diagnosis, pathogen isolation - culture matters: proceedings of international consensus on orthopedic infections. J Arthroplast 34:S197–S206
Cazanave C, Greenwood-Quaintance KE, Hanssen AD, Karau MJ, Schmidt SM, Gomez Urena EO, Mandrekar JN, Osmon DR, Lough LE, Pritt BS, Steckelberg JM, Patel R (2013) Rapid molecular microbiologic diagnosis of prosthetic joint infection. J Clin Microbiol 51:2280–2287
Fang X, Li W, Zhang C, Huang Z, Zeng H, Dong Z, Zhang W (2018) Detecting the presence of bacterial DNA and RNA by polymerase chain reaction to diagnose suspected Periprosthetic joint infection after antibiotic therapy: D iagnose of PJI by DNA and RNA- based PCR. Orthop Surg 10:40–46
Morgenstern M, Kuehl R, Zalavras CG, McNally M, Zimmerli W, Burch MA, Vandendriessche T, Obremskey WT, Verhofstad MHJ, Metsemakers WJ (2021) The influence of duration of infection on outcome of debridement and implant retention in fracture-related infection: a systematic review and critical appraisal. Bone Jt J 103-B:213–221
Bradbury T, Fehring TK, Taunton M, Hanssen A, Azzam K, Parvizi J, Odum SM (2009) The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplast 24:101–104
Lee SH, Oh JH, Lee KS, Yoo KH, Kim HS (2002) Infection after prosthetic reconstruction in limb salvage surgery. Int Orthop 26:179–184
Scholten R, Hannink G, Willemsen K, Mascini EM, Somford MP, Schreurs BW, van Susante JLC (2020) Preoperative Staphylococcus aureus screening and eradication: does it help to reduce early prosthetic joint infection? Bone Jt J 102-B:1341–1348